Company intelligence / Profile preview

AVACEN Medical

Carlsbad, California, United Statesavacen.com ↗

Ownership: Private
Development stage: Other

Overview

The company’s devices are FDA-cleared Class II medical devices for temporary relief of minor muscle/joint pain and related symptoms. Over ten thousand units have been sold with more than twenty-five million treatments reported without adverse events. Clinical results emphasize safety and efficacy in noninvasive microcirculation enhancement for chronic pain management. The technology has also received CE Mark approval in the EU for improving whole-body microcirculation—claimed to support wound healing processes such as diabetic foot ulcers.

Therapeutic areas: DermatologyRheumatologyNeurology
Modalities: DeviceNon-pharmacological therapyHeat therapy system
Industry: Therapeutic Medical Devices

Partnerships

Morulaa HealthTech (India distribution/wound care partnership)

Beyond the preview

Go deeper on AVACEN Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AVACEN Medical.

Explore the full profile